Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $703k | 500k | 1.41 |
| 2025-06-30 | $970k | 850k | 1.14 |
| 2025-03-31 | $1.5M | 1.2M | 1.28 |
| 2024-12-31 | $1.3M | 1.2M | 1.08 |
| 2024-09-30 | $477k | 400k | 1.19 |
| 2024-06-30 | $667k | 600k | 1.11 |
| 2024-03-31 | $585k | 600k | 0.97 |
| 2023-12-31 | $559k | 600k | 0.93 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1